-
-
-
-
-
-
-
Canaccord Reiterates Buy Rating on Compass Pathways (CMPS)
-
-
-
-
-
-
-
Compass Pathways (CMPS) PT Raised to $20 at Canaccord
-
-
-
-
-
-
-
Compass Pathways (CMPS) PT Raised to $22 at RBC Capital
-
-
-
-
-
-
-
FDA advances psychedelic drug studies for mental health treatment
-
-
-
-
-
-
-
COMPASS Pathways plc (CMPS) 3700 contracts of May 15 calls trade, share price up 5.8%
-
-
-
-
-
-
-
COMPASS Pathways plc (CMPS) call put ratio 5.5 calls to 1 put with a focus on May 8 calls
-
-
-
-
-
-
-
COMPASS Pathways plc (CMPS) 3K contracts of March 8 calls trade
-
433,077 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

